2024-12-13T09:19:59+08:00 weekly 1.0 https://www.prisysbiotech.com/ 2024-09-29T15:59:27+08:00 weekly 0.9 https://www.prisysbiotech.com/respiratory-disease-research 2024-09-29T14:11:22+08:00 weekly 0.9 https://www.prisysbiotech.com/metabolic-syndromes-research 2024-09-29T14:01:06+08:00 weekly 0.9 https://www.prisysbiotech.com/hematological-disease-research 2024-09-29T10:02:23+08:00 weekly 0.9 https://www.prisysbiotech.com/inflammation-immunology-disorders 2024-09-29T16:06:50+08:00 weekly 0.9 https://www.prisysbiotech.com/ophthalmic-disease-research 2024-09-29T14:11:55+08:00 weekly 0.9 https://www.prisysbiotech.com/cns-disorders-behavior-analysis 2023-02-27T15:56:40+08:00 weekly 0.9 https://www.prisysbiotech.com/co-develop 2025-02-25T10:49:21+08:00 weekly 0.9 https://www.prisysbiotech.com/translational-research-center 2024-08-16T16:34:54+08:00 weekly 0.9 https://www.prisysbiotech.com/animal-welfare 2024-12-02T15:58:14+08:00 weekly 0.9 https://www.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://www.prisysbiotech.com/fibrosis 2025-12-17T11:29:49+08:00 weekly 0.9 https://www.prisysbiotech.com/nephrology 2025-09-22T16:54:51+08:00 weekly 0.9 https://www.prisysbiotech.com/about-us 2025-02-11T14:42:33+08:00 weekly 0.9 https://www.prisysbiotech.com/contact-us 2023-02-24T14:00:35+08:00 weekly 0.9 https://www.prisysbiotech.com/newslist-1 2024-08-04T21:28:13+08:00 weekly 0.9 https://www.prisysbiotech.com/products 2023-03-31T08:14:22+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/ 2026-03-27T14:13:06+08:00 weekly 0.9 https://www.prisysbiotech.com/blog/ 2024-08-27T15:41:04+08:00 weekly 1.0 https://www.prisysbiotech.com/nhp-pharmacology/ 2023-03-21T14:49:44+08:00 weekly 0.9 https://www.prisysbiotech.com/pk-pd-adme/ 2023-03-21T14:52:00+08:00 weekly 0.9 https://www.prisysbiotech.com/safety-evaluation/ 2023-03-21T14:54:14+08:00 weekly 0.9 https://www.prisysbiotech.com/translation-research/ 2023-03-21T14:56:25+08:00 weekly 0.9 https://www.prisysbiotech.com/biosafety-research/ 2024-04-07T09:41:29+08:00 weekly 0.9 https://www.prisysbiotech.com/clearpoint/ 2026-01-06T16:11:35+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-02-27T15:06:38+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2025-09-30T14:54:03+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-10-09T15:32:34+08:00 weekly 0.8 https://www.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-08-08T16:43:29+08:00 weekly 0.8 https://www.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2025-01-22T14:30:09+08:00 weekly 0.8 https://www.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-12-31T16:50:26+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-09-26T15:06:29+08:00 weekly 0.8 https://www.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2025-01-22T13:38:22+08:00 weekly 0.8 https://www.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2025-01-22T15:16:06+08:00 weekly 0.8 https://www.prisysbiotech.com/pk-pd-adme/adme.html 2025-01-22T14:01:53+08:00 weekly 0.8 https://www.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2025-12-17T11:23:48+08:00 weekly 0.8 https://www.prisysbiotech.com/translation-research/translational-studies.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-10-08T14:43:53+08:00 weekly 0.8 https://www.prisysbiotech.com/translation-research/nhpresources.html 2024-10-09T14:10:03+08:00 weekly 0.8 https://www.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-09-20T16:43:16+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-09-05T14:13:39+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-09-11T16:33:16+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-09-10T13:52:13+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-08-16T15:07:25+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-08-12T13:52:59+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-08-16T13:58:39+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-08-12T14:42:45+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-08-27T11:00:43+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-08-05T11:27:27+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-08-05T10:28:07+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2025-01-16T15:45:37+08:00 weekly 0.8 https://www.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-09-19T09:31:53+08:00 weekly 0.8 https://www.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-08-05T13:09:13+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-10-09T13:17:48+08:00 weekly 0.8 https://www.prisysbiotech.com/translation-research/clinical-imaging.html 2024-08-16T14:20:51+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-08-27T16:53:47+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-10T14:13:21+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-20T16:09:15+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-20T16:20:31+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-20T16:30:01+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-20T17:10:34+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-10-09T16:59:19+08:00 weekly 0.8 https://www.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-11-29T13:23:57+08:00 weekly 0.8 https://www.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-01-20T17:08:37+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-01-21T10:16:47+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-03T13:44:15+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-05-15T13:24:27+08:00 weekly 0.8 https://www.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-09-29T13:05:58+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-16T10:41:28+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-29T10:31:47+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-23T14:30:29+08:00 weekly 0.8 https://www.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-28T14:41:22+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-10-24T14:37:50+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2025-12-31T11:32:00+08:00 weekly 0.8 https://www.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-01-30T13:45:40+08:00 weekly 0.8 https://www.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-02-28T16:06:32+08:00 weekly 0.8 https://www.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-03-04T13:39:26+08:00 weekly 0.8 https://www.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2023-02-20T14:52:48+08:00 weekly 0.9 https://www.prisysbiotech.com/newslist-704098-1 2023-02-20T14:52:58+08:00 weekly 0.9 https://www.prisysbiotech.com/newslist-704099-1 2024-07-25T09:05:48+08:00 weekly 0.9 https://www.prisysbiotech.com/newslist-817718-1 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-65118469.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-65118480.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/meetprisys-sot2023-65289337.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-65289458.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-65292284.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-sot2023-65309441.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-65868801.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-65869730.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/gene-therapy-nhp-model-65982243.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66021318.html 2023-04-05T20:50:59+08:00 weekly 0.8 https://www.prisysbiotech.com/news/gene-therapy-toxicology-66255392.html 2023-04-10T21:24:02+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-66365683.html 2023-04-11T16:49:00+08:00 weekly 0.8 https://www.prisysbiotech.com/news/world-parkinsons-disease-day-66451802.html 2023-04-14T21:49:01+08:00 weekly 0.8 https://www.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-66647316.html 2023-04-20T08:52:19+08:00 weekly 0.8 https://www.prisysbiotech.com/news/unleashing-the-therapeutic-potential-66755069.html 2023-04-22T12:12:52+08:00 weekly 0.8 https://www.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-66871028.html 2023-04-24T20:48:50+08:00 weekly 0.8 https://www.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-66972379.html 2023-04-27T21:38:57+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67072477.html 2023-05-02T22:15:48+08:00 weekly 0.8 https://www.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67234099.html 2024-02-27T14:41:16+08:00 weekly 0.8 https://www.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-67261254.html 2023-05-16T21:34:19+08:00 weekly 0.8 https://www.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-67485870.html 2023-07-11T09:54:59+08:00 weekly 0.8 https://www.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-67636731.html 2023-05-28T21:40:25+08:00 weekly 0.8 https://www.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-67883829.html 2023-07-11T09:31:15+08:00 weekly 0.8 https://www.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68171486.html 2023-07-11T09:27:58+08:00 weekly 0.8 https://www.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-68341249.html 2023-07-11T09:27:08+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-68511695.html 2023-07-11T09:25:32+08:00 weekly 0.8 https://www.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-68569921.html 2023-07-11T09:25:00+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-68691686.html 2023-07-11T09:24:30+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-68789172.html 2023-07-11T09:23:33+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-68913038.html 2024-02-27T14:39:46+08:00 weekly 0.8 https://www.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-68999887.html 2023-07-11T09:20:10+08:00 weekly 0.8 https://www.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69091216.html 2024-02-27T14:35:36+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69287481.html 2023-07-16T21:40:22+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309256.html 2023-07-25T22:05:40+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69508652.html 2023-07-30T21:48:38+08:00 weekly 0.8 https://www.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69612392.html 2023-08-03T17:19:16+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-69750453.html 2023-08-04T10:19:07+08:00 weekly 0.8 https://www.prisysbiotech.com/news/0-69771497.html 2023-08-07T10:45:11+08:00 weekly 0.8 https://www.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-69819158.html 2025-03-17T14:56:04+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-69895688.html 2023-08-21T22:00:06+08:00 weekly 0.8 https://www.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70267549.html 2023-08-31T14:33:54+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70568783.html 2023-09-18T22:14:15+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-71102162.html 2023-09-21T15:10:15+08:00 weekly 0.8 https://www.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-71191631.html 2023-10-27T13:18:42+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72058201.html 2023-10-29T20:23:59+08:00 weekly 0.8 https://www.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72115596.html 2023-11-07T10:14:26+08:00 weekly 0.8 https://www.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72320663.html 2023-11-21T10:59:12+08:00 weekly 0.8 https://www.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72672756.html 2024-02-27T14:31:22+08:00 weekly 0.8 https://www.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-72989311.html 2024-02-27T14:28:47+08:00 weekly 0.8 https://www.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73257744.html 2023-12-21T10:51:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73524306.html 2024-01-11T10:25:08+08:00 weekly 0.8 https://www.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74078496.html 2024-01-26T13:36:18+08:00 weekly 0.8 https://www.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654364.html 2024-02-27T14:23:40+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74780966.html 2024-07-22T14:18:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75125693.html 2024-02-21T13:22:33+08:00 weekly 0.8 https://www.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75157696.html 2024-03-27T14:46:03+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76172755.html 2024-04-26T16:07:35+08:00 weekly 0.8 https://www.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77051494.html 2024-04-29T11:20:05+08:00 weekly 0.8 https://www.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77138702.html 2024-07-22T14:17:02+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77525716.html 2024-06-07T16:57:14+08:00 weekly 0.8 https://www.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-78033350.html 2024-06-13T10:52:34+08:00 weekly 0.8 https://www.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-78078726.html 2024-07-03T11:15:25+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-78670960.html 2024-07-05T14:03:16+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-asthma-model-78789430.html 2024-08-01T11:24:30+08:00 weekly 0.8 https://www.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79081219.html 2024-08-01T11:23:56+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79222808.html 2024-08-01T11:23:28+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79288289.html 2024-08-01T11:31:39+08:00 weekly 0.8 https://www.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79409605.html 2024-08-01T11:23:01+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pk-strategies-of-pdc-79488179.html 2024-08-04T21:04:37+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79499354.html 2024-08-01T16:35:01+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79499370.html 2024-08-01T16:35:46+08:00 weekly 0.8 https://www.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79499376.html 2024-08-01T16:36:40+08:00 weekly 0.8 https://www.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79499390.html 2024-08-01T16:37:29+08:00 weekly 0.8 https://www.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79499392.html 2024-08-01T16:45:21+08:00 weekly 0.8 https://www.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79499435.html 2024-08-01T16:47:30+08:00 weekly 0.8 https://www.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79499452.html 2024-08-01T16:48:41+08:00 weekly 0.8 https://www.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79499467.html 2024-08-01T17:05:50+08:00 weekly 0.8 https://www.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79499545.html 2024-08-01T17:08:44+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79499549.html 2024-08-01T17:17:39+08:00 weekly 0.8 https://www.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79499574.html 2024-08-01T17:16:36+08:00 weekly 0.8 https://www.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79499584.html 2024-08-01T17:15:38+08:00 weekly 0.8 https://www.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79499602.html 2024-08-01T17:18:54+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79499606.html 2024-08-01T17:20:14+08:00 weekly 0.8 https://www.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79499608.html 2024-08-01T17:22:43+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79499615.html 2024-08-01T17:23:38+08:00 weekly 0.8 https://www.prisysbiotech.com/news/significance-principles-and-requirements-of-79499616.html 2024-08-01T17:25:30+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79499622.html 2024-08-01T17:26:26+08:00 weekly 0.8 https://www.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79499625.html 2024-08-01T17:27:32+08:00 weekly 0.8 https://www.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79499627.html 2024-08-01T17:29:21+08:00 weekly 0.8 https://www.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79499632.html 2024-08-01T17:31:31+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79499647.html 2024-08-01T17:33:24+08:00 weekly 0.8 https://www.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79499653.html 2024-08-01T17:37:00+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79499694.html 2024-08-01T17:39:14+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79499699.html 2024-08-01T17:40:05+08:00 weekly 0.8 https://www.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79499703.html 2024-08-20T17:14:54+08:00 weekly 0.8 https://www.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79499706.html 2024-08-01T17:43:18+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79499722.html 2024-08-01T17:44:25+08:00 weekly 0.8 https://www.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79499724.html 2024-08-01T17:45:17+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79499727.html 2024-08-01T17:48:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79499734.html 2024-08-01T17:49:53+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79499735.html 2024-08-09T17:12:32+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79499738.html 2024-08-09T17:14:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79499755.html 2024-08-01T17:54:42+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79499776.html 2024-08-01T17:56:04+08:00 weekly 0.8 https://www.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79499781.html 2024-08-01T17:59:15+08:00 weekly 0.8 https://www.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79499790.html 2024-08-01T18:03:06+08:00 weekly 0.8 https://www.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79499798.html 2024-08-01T18:03:28+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79499800.html 2024-08-01T18:05:04+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79499803.html 2024-08-01T18:06:34+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79499806.html 2024-08-01T18:07:15+08:00 weekly 0.8 https://www.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79499811.html 2024-08-01T18:09:51+08:00 weekly 0.8 https://www.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79499850.html 2024-08-01T18:11:01+08:00 weekly 0.8 https://www.prisysbiotech.com/news/mrna-based-therapies-present-79499852.html 2024-08-09T17:09:37+08:00 weekly 0.8 https://www.prisysbiotech.com/news/mrna-based-therapies-past-79499891.html 2024-08-01T18:12:49+08:00 weekly 0.8 https://www.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79499894.html 2024-08-06T21:50:03+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79648823.html 2024-08-09T17:01:24+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-79732476.html 2024-08-12T11:36:24+08:00 weekly 0.8 https://www.prisysbiotech.com/news/compartment-pk-model-79791922.html 2024-08-20T10:52:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-79996018.html 2024-08-27T10:28:34+08:00 weekly 0.8 https://www.prisysbiotech.com/news/convection-enhanced-delivery-80042287.html 2024-08-27T10:46:26+08:00 weekly 0.8 https://www.prisysbiotech.com/news/intranasal-administration-in-animal-studies-80166937.html 2024-08-28T14:56:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-80215248.html 2024-09-04T10:18:29+08:00 weekly 0.8 https://www.prisysbiotech.com/news/human-disease-animal-models-80573542.html 2024-09-06T10:01:34+08:00 weekly 0.8 https://www.prisysbiotech.com/news/rtimri-for-parkinsons-disease-80628952.html 2024-09-09T13:02:59+08:00 weekly 0.8 https://www.prisysbiotech.com/news/china-experimental-monkey-industry-80691218.html 2024-09-18T16:28:24+08:00 weekly 0.8 https://www.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-80834624.html 2024-09-20T15:37:29+08:00 weekly 0.8 https://www.prisysbiotech.com/news/animal-models-of-human-diseases-80912262.html 2024-09-24T11:02:00+08:00 weekly 0.8 https://www.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81044700.html 2024-09-24T17:00:45+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81061542.html 2024-09-29T13:30:12+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-81209739.html 2024-10-08T11:38:54+08:00 weekly 0.8 https://www.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-81350456.html 2024-10-14T09:12:16+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-81537688.html 2024-10-17T13:37:48+08:00 weekly 0.8 https://www.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-81664421.html 2024-10-29T10:28:43+08:00 weekly 0.8 https://www.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82015430.html 2024-11-06T16:16:02+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82201260.html 2024-11-08T14:01:40+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82249763.html 2024-11-11T14:12:37+08:00 weekly 0.8 https://www.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82316891.html 2024-11-15T11:19:11+08:00 weekly 0.8 https://www.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82435538.html 2024-11-19T10:58:37+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82571969.html 2024-11-26T16:33:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-82752836.html 2024-11-28T09:14:13+08:00 weekly 0.8 https://www.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-82805968.html 2024-12-03T10:07:39+08:00 weekly 0.8 https://www.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-82949342.html 2024-12-04T14:25:53+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-82982616.html 2024-12-09T11:16:36+08:00 weekly 0.8 https://www.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83070234.html 2024-12-16T13:26:47+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83294879.html 2024-12-20T11:30:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83383757.html 2024-12-24T16:48:47+08:00 weekly 0.8 https://www.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83462517.html 2024-12-27T17:24:05+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83539913.html 2024-12-30T16:25:17+08:00 weekly 0.8 https://www.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83629603.html 2025-01-02T14:35:54+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83732371.html 2025-01-07T10:34:46+08:00 weekly 0.8 https://www.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83880762.html 2025-01-12T20:28:49+08:00 weekly 0.8 https://www.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-84044728.html 2025-01-15T13:39:34+08:00 weekly 0.8 https://www.prisysbiotech.com/news/animal-brain-stereotactic-instruments-84118854.html 2025-01-17T15:35:51+08:00 weekly 0.8 https://www.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-84187434.html 2025-01-21T10:54:55+08:00 weekly 0.8 https://www.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-84276729.html 2025-01-24T13:44:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-84380546.html 2025-02-05T14:29:28+08:00 weekly 0.8 https://www.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-84496354.html 2025-02-12T14:33:35+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-84623131.html 2025-02-14T13:37:04+08:00 weekly 0.8 https://www.prisysbiotech.com/news/animal-models-challenges-and-applications-in-84683472.html 2025-03-28T17:03:47+08:00 weekly 0.8 https://www.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-84813344.html 2025-03-28T17:04:35+08:00 weekly 0.8 https://www.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-84873696.html 2025-02-25T09:49:43+08:00 weekly 0.8 https://www.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-84929568.html 2025-03-28T17:05:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-84945674.html 2025-03-28T17:06:20+08:00 weekly 0.8 https://www.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-84948246.html 2025-03-28T17:06:52+08:00 weekly 0.8 https://www.prisysbiotech.com/news/animal-models-for-womens-health-84949718.html 2025-03-10T17:49:42+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-84952121.html 2025-03-17T10:12:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/membranous-nephropathy-model-84956087.html 2025-03-28T17:09:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-84959110.html 2025-03-28T17:08:30+08:00 weekly 0.8 https://www.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-84962874.html 2025-03-28T17:07:20+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-84967674.html 2025-04-01T10:25:15+08:00 weekly 0.8 https://www.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-84970196.html 2025-04-08T09:45:35+08:00 weekly 0.8 https://www.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-84980497.html 2025-04-11T16:26:45+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-84986103.html 2025-04-16T09:56:43+08:00 weekly 0.8 https://www.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-84991972.html 2025-04-18T09:38:49+08:00 weekly 0.8 https://www.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-84995754.html 2025-04-22T10:23:13+08:00 weekly 0.8 https://www.prisysbiotech.com/news/intracerebroventricular-icv-injection-84998730.html 2026-01-27T12:41:25+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-85001870.html 2025-04-29T16:46:12+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-85015654.html 2025-04-30T15:24:53+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-85016603.html 2025-05-08T16:59:32+08:00 weekly 0.8 https://www.prisysbiotech.com/news/aso-pharmacokinetics-absorption-85029666.html 2025-05-12T17:44:11+08:00 weekly 0.8 https://www.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-85031855.html 2025-05-20T12:51:03+08:00 weekly 0.8 https://www.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-85053350.html 2025-05-23T17:01:21+08:00 weekly 0.8 https://www.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-85095830.html 2025-05-27T15:51:31+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-85098638.html 2025-05-30T14:25:38+08:00 weekly 0.8 https://www.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-85101101.html 2025-06-05T12:50:57+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cynomolgus-monkey-pain-models-85104948.html 2025-06-10T10:02:44+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-85107952.html 2025-06-13T17:07:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-85130919.html 2025-06-17T13:19:07+08:00 weekly 0.8 https://www.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-85132565.html 2025-06-19T16:15:48+08:00 weekly 0.8 https://www.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-85134254.html 2025-06-26T09:36:39+08:00 weekly 0.8 https://www.prisysbiotech.com/news/key-considerations-for-dosing-volume-85137808.html 2025-06-30T17:01:40+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-85140777.html 2025-07-04T13:57:51+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-85145631.html 2025-07-08T09:52:50+08:00 weekly 0.8 https://www.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-85147497.html 2025-07-10T15:01:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-85149878.html 2025-07-18T16:17:30+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-85155643.html 2025-07-22T16:39:13+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-acute-hemorrhage-model-85158325.html 2025-07-30T12:52:23+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-copd-model-85167253.html 2025-07-31T15:39:25+08:00 weekly 0.8 https://www.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-85168658.html 2025-08-05T09:56:01+08:00 weekly 0.8 https://www.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-85171398.html 2025-08-13T09:58:14+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-85178082.html 2025-08-18T14:02:06+08:00 weekly 0.8 https://www.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-85182313.html 2025-08-20T13:39:32+08:00 weekly 0.8 https://www.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-85185053.html 2025-08-22T15:39:45+08:00 weekly 0.8 https://www.prisysbiotech.com/news/brain-targeted-drug-delivery-85187850.html 2025-08-26T14:27:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/the-importance-of-administration-volume-85190974.html 2025-09-03T10:19:49+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-85208577.html 2025-09-09T16:35:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-85215761.html 2025-09-12T15:20:44+08:00 weekly 0.8 https://www.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-85223850.html 2025-09-19T14:23:38+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-85234105.html 2025-09-29T13:07:12+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-85255565.html 2025-10-10T11:28:10+08:00 weekly 0.8 https://www.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-85264181.html 2025-10-11T13:36:22+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-85265109.html 2025-10-15T17:50:40+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-85268150.html 2025-10-17T16:54:38+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pk-study-targeted-drug-delivery-85270085.html 2025-10-22T17:23:53+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-renal-biopsy-85273405.html 2025-10-28T16:44:03+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-85278712.html 2025-11-05T14:46:31+08:00 weekly 0.8 https://www.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-85286025.html 2025-11-07T16:07:33+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-85288900.html 2025-12-01T13:50:16+08:00 weekly 0.8 https://www.prisysbiotech.com/news/rfp-template-for-nhp-studies-85291288.html 2025-11-14T16:24:34+08:00 weekly 0.8 https://www.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-85304658.html 2025-12-01T13:48:57+08:00 weekly 0.8 https://www.prisysbiotech.com/news/th17-driven-nhp-immunology-models-85305359.html 2025-11-21T08:43:18+08:00 weekly 0.8 https://www.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-85308901.html 2025-11-24T15:48:27+08:00 weekly 0.8 https://www.prisysbiotech.com/news/parkinsons-disease-preclinical-models-85310806.html 2025-11-28T14:12:24+08:00 weekly 0.8 https://www.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-85314557.html 2025-12-01T11:23:54+08:00 weekly 0.8 https://www.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-85315687.html 2025-12-04T13:44:35+08:00 weekly 0.8 https://www.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-85322130.html 2025-12-08T14:11:55+08:00 weekly 0.8 https://www.prisysbiotech.com/news/one-to-multi-compartment-pk-models-85344923.html 2025-12-12T14:46:40+08:00 weekly 0.8 https://www.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-85349895.html 2025-12-16T15:06:17+08:00 weekly 0.8 https://www.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-85353605.html 2025-12-18T16:13:32+08:00 weekly 0.8 https://www.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-85355535.html 2025-12-23T16:19:31+08:00 weekly 0.8 https://www.prisysbiotech.com/news/imri-guided-brain-drug-delivery-85361526.html 2025-12-26T15:59:02+08:00 weekly 0.8 https://www.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-85368281.html 2026-01-04T16:26:50+08:00 weekly 0.8 https://www.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-85377566.html 2026-01-06T13:09:56+08:00 weekly 0.8 https://www.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-85379092.html 2026-01-09T17:09:24+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-85388008.html 2026-01-13T17:03:03+08:00 weekly 0.8 https://www.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-85390014.html 2026-01-15T10:56:49+08:00 weekly 0.8 https://www.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-85391545.html 2026-01-20T16:05:31+08:00 weekly 0.8 https://www.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-85404723.html 2026-01-23T15:54:09+08:00 weekly 0.8 https://www.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-85407506.html 2026-01-27T13:16:41+08:00 weekly 0.8 https://www.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-85409852.html 2026-02-13T14:25:34+08:00 weekly 0.8 https://www.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-85447875.html 2026-02-14T12:03:36+08:00 weekly 0.8 https://www.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-85448030.html 2026-02-28T08:56:14+08:00 weekly 0.8 https://www.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-85449610.html 2026-03-10T15:41:20+08:00 weekly 0.8 https://www.prisysbiotech.com/news/evaluating-dmpk-properties-85457858.html 2026-03-13T14:28:49+08:00 weekly 0.8 https://www.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-85463894.html 2026-03-17T15:02:04+08:00 weekly 0.8 https://www.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-85478240.html 2026-03-20T12:01:26+08:00 weekly 0.8 https://www.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-85482217.html 2026-03-23T11:12:09+08:00 weekly 0.8 https://www.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-85483899.html 2026-03-27T17:32:07+08:00 weekly 0.8 https://www.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-85489764.html 2023-03-22T16:23:31+08:00 weekly 0.9 https://www.prisysbiotech.com/others/privacy.html 2026-02-25T10:51:14+08:00 weekly 0.8 https://www.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-26T05:02:11+08:00 weekly 0.8 https://www.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-03-02T05:02:21+08:00 weekly 0.8 https://www.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-04T05:02:23+08:00 weekly 0.8 https://www.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-12T05:03:02+08:00 weekly 0.8 https://www.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-27T05:04:40+08:00 weekly 0.8 https://www.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nucleotide-pd/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/vaccine-pd/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-safety-evaluation/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/vaccine-pk/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/testing-monkeys/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/testing-on-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/testing-clinical-trials/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/preclinical-pharmacology-and-toxicology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-drug-target/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/translational/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/translational-toxicology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-translation/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/immuno-toxicity/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/in-vivo-toxicity/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/toxicity-in-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/toxicology-contractorganizations/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/biomedical-toxicology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/chronic-toxicology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/acute-toxicology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/toxicity-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/toxicity-assessment/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-safety-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/glp-tox/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/laboratory-of-toxicology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/acute-toxicity/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/safety-toxicology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/safety-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/drug-absorption-and-distribution/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-biodistribution/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/adme-of-drug/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/pk-and-pd/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/adme-pharmacodynamics/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/non-human-primate-pd/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/preclinical-pk-pd/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/in-vivo-pharmacokinetics/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/in-vivo-pk/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/non-human-primate-pk/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/veterinary-pk/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/preclinical-contract/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-pharmacodynamics/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/preclinical/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-pharmacokinetics/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-cro-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-clinical-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-atopic-dermatitis-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-asthma-dermatitis-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-biodistribution-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-biomarker-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-lung-fibrosis/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-efficacy-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-drug-target-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-copd-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-chronic-obstructive-pulmonary-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-biosafety-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-infectious-disease-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-nash-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-non-alcoholic-steatohepatitis-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-translation-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-nonclinical-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/aki-to-ckd-transition/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/non-human-primate-model-renal-ischemia-reperfusion-injury/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-diseasepharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-pharmacology-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/hemophilia-a-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-toxicology-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-pharmacodynamics-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/coagulation-hemostasis-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-pharmacokinetics-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-dmpk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/acute-myocardial-infarction-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-safety-evaluation-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/embolism-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/protein-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/pulmonary-artery-hypertension-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/peptide-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/vaccine-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/myopia-hyperopia-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/rna-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/antibody-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/uveitis-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nucleotide-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/amd-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/biologics-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/drug-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/glaucoma-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/veterinary-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/experimentalpd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/psoriasis-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/dth-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/non-human-primate-pd-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/protein-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/inflammatory-bowel-disease-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/peptide-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/vaccine-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/tdar-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/rna-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/antibody-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/rheumatoid-arthritis-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nucleotide-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/multiple-sclerosis-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/biologics-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/drug-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/mcao-nhp-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/veterinary-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/experimental-pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/epilepsy-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/pk-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/neuropathic-pain-nonhuman-primates/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/in-vivo-and-in-vitro-pharmacology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-preclinical/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/cynomolgus/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-company/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/neuropathic-pain-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/epilepsy-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/middle-cerebral-artery-occlusion-mcao-nhp-model-of-stoke-brain-ischemia/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/multiple-sclerosis-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/rheumatoid-arthritis-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/t-cell-dependent-antibody-response-tdar-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/inflammatory-bowel-disease-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/delayed-type-hypersensitivity-dth-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/psoriasis-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/glaucoma-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/amd-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/uveitis-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/myopia-hyperopia-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/pulmonary-artery-hypertension-embolism-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/acute-myocardial-infarction-heart-failure-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/coagulation-hemostasis-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/hemophilia-a-nonhuman-primates-disease-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/non-human-primate-model-renal-ischemia-reperfusion-injury-aki-to-ckd-transition-/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-non-alcoholic-steatohepatitis-nash-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-chronic-obstructive-pulmonary-disease-copd-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-lung-fibrosis-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-asthma-atopic-dermatitis-model/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/bsl2-laboratory/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nonhuman-primate-resources/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/new-and-modified-applications/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/translational-studies/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/immunotoxicity/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/toxicology/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/adme/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/pharmacodynamics/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/pharmacokinetics/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-monkey-disease-models/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/single-dose-repeated-dose-toxicity-testing/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/dose-range-finding-test/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/toxicokinetics-tk-/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/prisys-nonhuman-primate-disease-models/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/what-is-a-nhp-study/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/non-human-primate-nhp-/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-resources/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/biosafety-research/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/safety-evaluation/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/pk-pd-adme/ 2026-03-27T17:41:30+08:00 weekly 0.9 https://www.prisysbiotech.com/showroom/nhp-pharmacology/